Micron Stock Could Be Worth Buying Before Its Next Earnings Report
Risk factors are real, but Micron could have what it takes to end 2026 on a high note.
Mindfully Curated
Risk factors are real, but Micron could have what it takes to end 2026 on a high note.
Although neither Travelers nor Chubb is cheap today, strong operating results may interest growth-minded investors.
Nuclear power is in the spotlight, but these two stocks have tumbled over the past year. Here’s which sold-off stock is a better buy right now.
Arista boasts a high profit margin and zero debt, while CrowdStrike just reported its best quarter in history because of AI.
Solid-state battery maker launches 100 MWh mass production line targeting 2028.
Defense sales plunged 95%, but first-half revenue surged 36% on distributor strength.
Record net interest income and expanded margins drove sequential earnings growth.
Cloud revenue surged 25% as AI adoption drove productivity gains across enterprise software.
Truckload margins recovered as pricing gains and efficiency improved operating ratio 450 basis points.
Record combined ratio of 84.7% and 30% submission growth signal strong underwriting momentum.
Rocket Lab’s Neutron setback forces investors to reassess launch timelines and valuation.
Commercial finance segment drives results; management guides fiscal 2027 EPS to $9.50–$10.00.
High-end softness pressured results despite strong mass gaming growth.
Software revenue accelerated 9% as AI deployment modernization drove consulting demand.
Management guides 4% to 7% FY2027 growth as premiumization gains accelerate.
Record results fuel $14.4B project backlog expansion.
Tower operator pivots to pure-play model while targeting 400+ ground lease buyouts in 2026.
Record industrial revenue and 95% data center growth highlight broad cyclical recovery.
Margin expansion and record revenue powered by operational efficiency and intermodal strength.
Revenue surged 26% as AI tools and Muse adoption drive engagement gains.